Cornercap Investment Counsel Inc Shattuck Labs, Inc. Transaction History

Cornercap Investment Counsel Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.42 - $3.16 $866 - $1,927	610 Added 1.21%	50,973 $77,000
Q2 2023 Aug 11, 2023	BUY	$2.52 - $3.66 $909 - $1,321	361 Added 0.72%	50,363 $157,000
Q1 2023 May 11, 2023	BUY	$2.5 - $4.72 $7,687 - $14,514	3,075 Added 6.55%	50,002 $147,000
Q4 2022 Feb 13, 2023	BUY	$1.96 - $3.26 $842 - $1,401	430 Added 0.92%	46,927 $107,000
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.52 $4,303 - $9,135	1,655 Added 3.69%	46,497 $126,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $4.59 $121,073 - $205,824	44,842 New	44,842 $182,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $46.6M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.